blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1027037

EP1027037 - PHARMACEUTICAL PREPARATION COMPRISING CLODRONATE AS ACTIVE INGREDIENT AND SILICIFIED MICROCRYSTALLINE CELLULOSE AS EXCIPIENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.10.2004
Database last updated on 16.09.2024
Most recent event   Tooltip08.10.2004No opposition filed within time limitpublished on 24.11.2004  [2004/48]
Applicant(s)For all designated states
Schering Oy
Pansiontie 47
20210 Turku / FI
[2003/29]
Former [2000/33]For all designated states
LEIRAS OY
Pansiontie 45-47
20210 Turku / FI
Inventor(s)01 / LEHTOLA, Veli-Matti
Ilkanrinne 2 A 16
FIN-20810 Turku / FI
02 / RANTALA, Eeva-Maria, Susanne
Joukahaisentie 17
FIN-21530 Paimio / FI
03 / RANTALA, Pertti, Tapani
Kierrekuja 3
FIN-20660 Littoinen / FI
[2000/33]
Representative(s)Grew, Eva Regina, et al
Oy Jalo Ant-Wuorinen Ab
Iso Roobertinkatu 4-6-A
00120 Helsinki / FI
[N/P]
Former [2000/33]Grew, Eva Regina, et al
Oy Jalo Ant-Wuorinen Ab Iso Roobertinkatu 4-6-A
00120 Helsinki / FI
Application number, filing date98945336.018.09.1998
[2000/33]
WO1998FI00735
Priority number, dateFI1997000373319.09.1997         Original published format: FI 973733
[2000/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9915155
Date:01.04.1999
Language:EN
[1999/13]
Type: A1 Application with search report 
No.:EP1027037
Date:16.08.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.1999 takes the place of the publication of the European patent application.
[2000/33]
Type: B1 Patent specification 
No.:EP1027037
Date:03.12.2003
Language:EN
[2003/49]
Search report(s)International search report - published on:SE01.04.1999
ClassificationIPC:A61K9/20, A61K9/48, A61K47/38, A61K31/66
[2000/33]
CPC:
A61K31/663 (EP); A61K9/20 (KR); A61K9/2009 (EP);
A61K9/2054 (EP); A61P19/00 (EP); A61P19/08 (EP);
A61P19/10 (EP); A61P3/14 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2000/33]
Extension statesLT13.03.2000
LV13.03.2000
MK13.03.2000
RO13.03.2000
SI13.03.2000
TitleGerman:ARZNEIMITTEL, DAS CLODRONAT ALS WIRKSTOFF UND MIT SILICIUMDIOXID BEHANDELTE MIKROKRISTALLINE CELLULOSE ALS FÜLLSTOFF ENTHÄLT[2003/18]
English:PHARMACEUTICAL PREPARATION COMPRISING CLODRONATE AS ACTIVE INGREDIENT AND SILICIFIED MICROCRYSTALLINE CELLULOSE AS EXCIPIENT[2000/33]
French:PREPARATION PHARMACEUTIQUE COMPRENANT DU CLODRONATE EN TANT QUE PRINCIPE ACTIF ET DE LA CELLULOSE MICROCRISTALLINE SILICIFIEE EN TANT QU'EXCIPIENT[2000/33]
Former [2000/33]ARZNEIMITTEL, DAS CLODRONAT ALS WIRKSTOFF UND MIT SILICIUMDIOXID BEHANDELTE MIKROKRISTALLINE CELLULOSE ALS FÜLLSSTOFF ENHÄLT
Entry into regional phase13.03.2000National basic fee paid 
13.03.2000Designation fee(s) paid 
13.03.2000Examination fee paid 
Examination procedure19.03.1999Request for preliminary examination filed
International Preliminary Examining Authority: SE
13.03.2000Examination requested  [2000/33]
30.08.2002Despatch of a communication from the examining division (Time limit: M04)
23.12.2002Reply to a communication from the examining division
11.04.2003Communication of intention to grant the patent
22.07.2003Fee for grant paid
22.07.2003Fee for publishing/printing paid
Opposition(s)06.09.2004No opposition filed within time limit [2004/48]
Fees paidRenewal fee
13.03.2000Renewal fee patent year 03
21.09.2001Renewal fee patent year 04
21.09.2002Renewal fee patent year 05
22.09.2003Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9426310  (BOEHRINGER MANNHEIM GMBH [DE], et al);
 [A]WO9513054  (LEIRAS OY [FI], et al);
 [X]WO9621429  (MENDELL CO INC EDWARD [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.